1. Home
  2. VNDA vs CIX Comparison

VNDA vs CIX Comparison

Compare VNDA & CIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • CIX
  • Stock Information
  • Founded
  • VNDA 2002
  • CIX 1993
  • Country
  • VNDA United States
  • CIX United States
  • Employees
  • VNDA N/A
  • CIX N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • CIX Industrial Machinery/Components
  • Sector
  • VNDA Health Care
  • CIX Consumer Discretionary
  • Exchange
  • VNDA Nasdaq
  • CIX Nasdaq
  • Market Cap
  • VNDA 261.7M
  • CIX 301.8M
  • IPO Year
  • VNDA 2006
  • CIX 1998
  • Fundamental
  • Price
  • VNDA $5.02
  • CIX $26.90
  • Analyst Decision
  • VNDA Strong Buy
  • CIX
  • Analyst Count
  • VNDA 3
  • CIX 0
  • Target Price
  • VNDA $15.33
  • CIX N/A
  • AVG Volume (30 Days)
  • VNDA 414.8K
  • CIX 6.7K
  • Earning Date
  • VNDA 07-30-2025
  • CIX 08-05-2025
  • Dividend Yield
  • VNDA N/A
  • CIX 4.55%
  • EPS Growth
  • VNDA N/A
  • CIX N/A
  • EPS
  • VNDA N/A
  • CIX 1.46
  • Revenue
  • VNDA $201,351,000.00
  • CIX $148,242,000.00
  • Revenue This Year
  • VNDA $16.86
  • CIX N/A
  • Revenue Next Year
  • VNDA $39.78
  • CIX N/A
  • P/E Ratio
  • VNDA N/A
  • CIX $18.10
  • Revenue Growth
  • VNDA 13.37
  • CIX N/A
  • 52 Week Low
  • VNDA $3.81
  • CIX $17.89
  • 52 Week High
  • VNDA $6.37
  • CIX $36.10
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 67.29
  • CIX 56.89
  • Support Level
  • VNDA $4.66
  • CIX $22.81
  • Resistance Level
  • VNDA $4.95
  • CIX $27.01
  • Average True Range (ATR)
  • VNDA 0.15
  • CIX 1.12
  • MACD
  • VNDA 0.03
  • CIX 0.21
  • Stochastic Oscillator
  • VNDA 89.39
  • CIX 67.55

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

Share on Social Networks: